BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23295831)

  • 1. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer.
    Ying L; Huang Y; Chen H; Wang Y; Xia L; Chen Y; Liu Y; Qiu F
    Mol Biosyst; 2013 Mar; 9(3):407-11. PubMed ID: 23295831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis.
    Qin R; Chen Z; Ding Y; Hao J; Hu J; Guo F
    Neoplasma; 2013; 60(5):486-92. PubMed ID: 23790166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.
    Wang P; Ren Z; Sun P
    J Cell Biochem; 2012 Jun; 113(6):1868-74. PubMed ID: 22234798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.
    Luo M; Li Z; Wang W; Zeng Y; Liu Z; Qiu J
    FEBS J; 2013 Apr; 280(7):1709-16. PubMed ID: 23399020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
    Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
    J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3.
    Xiu YL; Sun KX; Chen X; Chen S; Zhao Y; Guo QG; Zong ZH
    Oncotarget; 2017 May; 8(19):31714-31725. PubMed ID: 28423647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
    Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
    Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.
    Takahashi H; Nakatsuji H; Takahashi M; Avirmed S; Fukawa T; Takemura M; Fukumori T; Kanayama H
    Urology; 2012 Jan; 79(1):240.e1-8. PubMed ID: 22119253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.
    Ying L; Chen Q; Wang Y; Zhou Z; Huang Y; Qiu F
    Mol Biosyst; 2012 Sep; 8(9):2289-94. PubMed ID: 22722759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells.
    Zhang Y; Zou Y; Wang W; Zuo Q; Jiang Z; Sun M; De W; Sun L
    J Cell Biochem; 2015 Apr; 116(4):542-50. PubMed ID: 25358633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer.
    Wang Y; Chen W; Yang C; Wu W; Wu S; Qin X; Li X
    Int J Oncol; 2012 Jul; 41(1):276-84. PubMed ID: 22576688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non‑coding RNA MEG3 contributes to cisplatin‑induced apoptosis via inhibition of autophagy in human glioma cells.
    Ma B; Gao Z; Lou J; Zhang H; Yuan Z; Wu Q; Li X; Zhang B
    Mol Med Rep; 2017 Sep; 16(3):2946-2952. PubMed ID: 28677749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
    Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
    Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Gao J; Zhu J; Li HY; Pan XY; Jiang R; Chen JX
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1294-304. PubMed ID: 21601006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
    Sun L; Li Y; Yang B
    Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
    Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
    Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
    FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.